This 1.5 hour internet symposium will review and discuss the key studies on antiretroviral therapy presented at the 17th Conference on Retroviruses and Opportunistic Infections.* The symposium will feature 5 well-known and recognized thought leaders in the HIV field, with 4 serving as presenting faculty/discussants and 1 as program moderator.
This program is certified for CME credit for US physicians by the Postgraduate Institute for Medicine. This program is for health care providers who treat HIV-positive patients, there are no prerequisites.
Program Note: While there is mutual recognition of CME credits between Europe and the US, an application has been submitted to the European Union of Medical Specialists (UEMS) for approval to provide direct EACCME accredited continuing medical education for European participants.
This activity has been designed to meet the educational need of physicians involved in the care of patients with HIV infection.
Following this program, participants will be able to:
Explain the key new studies on ARV therapy presented at the 17th CROI
Outline how to use the advances in clinical management of HIV-positive patients presented and discussed at the 17th CROI to improve patient care
Describe how to apply data presented and discussed at the 17th CROI regarding the treatment of ARV-naïve and experienced patients
Analyze treatment options and construct appropriate ARV regimens
John Bartlett, MD
Professor, Johns Hopkins University
School of Medicine
Baltimore, Maryland
Jose Arribas, MD,
Senior Attending Physician, HIV Unit
Hospital de La Paz
Madrid, Spain
David Cooper, MD
Professor, University of New South Wales
Director of The National Centre in Epidemiology & Clinical Research
Sydney, Australia
Joseph Eron, MD
Professor, University of North Carolina
School of Medicine
Chapel Hill, North Carolina
Jurgen Rockstroh, MD
Professor, University of Bonn
Bonn, Germany
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and ViralEd, Inc.. PIM is accredited by the ACCME to provide continuing medical education for physicians.
Postgraduate Institute for Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by PIM for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The faculty reported the following financial relationships or relationships to products or devices they or thier spouse/life partner have with commercial interests related to the content of these CME activities:
Dr. John Bartlett:
Dr. Joseph Eron:
Dr. Jose Arribas:
Dr. David Cooper:
Dr. Juergen Rockstroh:
The planners and managers reported the following financial relationships or relationships to products or devices they or thier spouse/life partner have with commercial interests related to the content of these CME activities:
The following PIM planners and managers: Jan Hixon, RN, BSN, MS, Trace Hutchison, PharmD, Julia Kirkwood, RN, BSN, Samantha Mattiucci, PharmD and Jan Schultz, RN, MSN, CCMEP hereby state that they or their spouse/life partner do not have any financial relationships to products or devices with any commercial interest related to the content of these activities of any amount during the past 12 months.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine (PIM), ViralEd, Inc., and Merck & Co., Inc. do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, ViralEd, Inc., and Merck & Co., Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
There are no fees for participating and receiving credit for this activity. During the period, February 22 - February 24, 2010, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; and 3) complete the evaluation form.
To take the post-test for the CROI eSympoisum that took place on February 22, 23 or 24 click here: CROI eSymposium CME Evaluation
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Supported by an educational grant from Merck & Co., Inc.
*This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings
